rxstat › Shortages › Valsartan
Valsartan shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Valsartan products are in shortage in Canada (3 of 43 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 19, 2026.
In shortage since
Feb 5, 2025
Est. full return
Jun 19, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTARO-VALSARTAN
40MG · TABLET · SUN PHARMA CANADA INC
DIN 02363062 · since Mar 11, 2026, est. end Jun 19, 2026 · Disruption of the manufacture of the drug.
Active shortageTEVA-VALSARTAN
160MG · TABLET · TEVA CANADA LIMITED
DIN 02356678 · since Feb 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortageTEVA-VALSARTAN
80MG · TABLET · TEVA CANADA LIMITED
DIN 02356651 · since Sep 2, 2025, no end estimate · Disruption of the manufacture of the drug.
ResolvedTARO-VALSARTAN
80MG · TABLET · SUN PHARMA CANADA INC
DIN 02363100 · ended Mar 26, 2026 · Disruption of the manufacture of the drug.
ResolvedAURO-VALSARTAN
320MG · TABLET · AURO PHARMA INC
DIN 02414244 · ended Nov 27, 2025 · Demand increase for the drug.
ResolvedAURO-VALSARTAN
160MG · TABLET · AURO PHARMA INC
DIN 02414236 · ended Nov 27, 2025 · Demand increase for the drug.
ResolvedAURO-VALSARTAN
80MG · TABLET · AURO PHARMA INC
DIN 02414228 · ended Nov 27, 2025 · Delay in shipping of the drug.
ResolvedAURO-VALSARTAN
40MG · TABLET · AURO PHARMA INC
DIN 02414201 · ended Sep 24, 2025 · Demand increase for the drug.
ResolvedTARO-VALSARTAN
160MG · TABLET · SUN PHARMA CANADA INC
DIN 02363119 · ended Jul 8, 2025 · Disruption of the manufacture of the drug.
DiscontinuedTEVA-VALSARTAN
40MG · TABLET · TEVA CANADA LIMITED
DIN 02356643
DiscontinuedTEVA-VALSARTAN
80MG · TABLET · TEVA CANADA LIMITED
DIN 02356651
DiscontinuedTEVA-VALSARTAN
160MG · TABLET · TEVA CANADA LIMITED
DIN 02356678
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Valsartan is currently affected by 3 active shortage reports filed with Health Canada by SUN PHARMA CANADA INC, TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Valsartan is classified under “ANGIOTENSIN II ANTAGONISTS, PLAIN” (ATC C09CA).
Recent changes
Common questions
When will Valsartan be back in stock in Canada?
The latest manufacturer estimate is Jun 19, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Valsartan in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.